Clinical Presentation and Molecular Characterization of 3 Patients with Vici Syndrome: Two Novel Variants in the EPG5 Gene
Molecular Syndromology · 2024 · 15 (3) · 257-268
DOI: 10.1159/000536069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Syndromology, online erschienen am 01.02.2024. Verfasst von Arzu Selamioğlu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Nutrition and Metabolism, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction: Vici syndrome is an ultra-rare, congenital disorder of autophagy characterized by agenesis of the corpus callosum, cataracts, cardiomyopathy, combined immunodeficiency, developmental delay, and hypopigmentation. Patients usually present in the neonatal period or infancy with profound hypotonia, based on information available from the nearly 100 cases reported to date. Case Presentation: We present 3 new cases of Vici syndrome confirmed by genetic analysis of EPG5 gene. The 3 male patients had neonatal hypotonia, progressive microcephaly, psychomotor retardation, recurrent respiratory tract infections, optic atrophy, and failure to thrive, but no cataracts or hepatomegaly. Three disease-causing variants in homozygous state were detected in the EPG5 gene: two novel c.1652C>T and c.7557+2T>C forms; and one previously reported c.7447C>T. The patient, who was homozygous for the c.1652C>T mutation, presented with neonatal onset seizures that had not been reported previously. Discussion/Conclusion: The present study provides data for the evaluation of the natural history and genotype-phenotype correlations for treatment options that are expected to be available in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Nutrition and Metabolism, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
- Division of Pediatric Genetics, Umraniye Training and Research Hospital, Istanbul, Turkey.
- Division of Medical Genetics, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
Zitieren
APA
Selamioğlu, A., Doğan, B. Y., Balcı, M. C., Kalaycı, T., Karaca, M., Ak, B., Durmuş, A., Körbeyli, H. K., & Gökçay, G. (2024). Clinical Presentation and Molecular Characterization of 3 Patients with Vici Syndrome: Two Novel Variants in the EPG5 Gene. Molecular Syndromology, 15(3), 257-268. https://doi.org/10.1159/000536069
Vancouver
Selamioğlu A, Doğan BY, Balcı MC, Kalaycı T, Karaca M, Ak B, et al. Clinical Presentation and Molecular Characterization of 3 Patients with Vici Syndrome: Two Novel Variants in the EPG5 Gene. Molecular Syndromology. 2024;15(3):257-268. doi:10.1159/000536069
BibTeX
@article{Selamiolu2024,
author = {Selamioğlu, Arzu and Doğan, Burcu Yeter and Balcı, Mehmet Cihan and Kalaycı, Tuğba and Karaca, Meryem and Ak, Belkıs and Durmuş, Aslı and Körbeyli, Hüseyin Kutay and Gökçay, Gülden},
title = {Clinical Presentation and Molecular Characterization of 3 Patients with Vici Syndrome: Two Novel Variants in the EPG5 Gene},
journal = {Molecular Syndromology},
year = {2024},
volume = {15},
number = {3},
pages = {257--268},
doi = {10.1159/000536069}
}
EUVIMED